Protara Therapeutics, Inc. (NASDAQ:TARA – Get Free Report) was the target of a significant growth in short interest in April. As of April 15th, there was short interest totalling 398,300 shares, a growth of 510.9% from the March 31st total of 65,200 shares. Approximately 4.4% of the shares of the company are short sold. Based […]